Keros Therapeutics, Inc. (KROS) has a market capitalization of $429.91M and trades at $11.55. The 52-week range is 9.12-22.55.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 4.9, Earnings Per Share (EPS) of $2.34, annual revenue of $244.06M.
The stock has a beta of 0.99, operates in the Healthcare sector.
